These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 18847072

  • 1. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L, Modha K, Albaddawi E, Subramanian S.
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract] [Full Text] [Related]

  • 2. Sodium-wasting nephropathy caused by cisplatin in a patient with small-cell lung cancer.
    Iyer AV, Krasnow SH, Dufour DR, Arcenas AS.
    Clin Lung Cancer; 2003 Nov; 5(3):187-9. PubMed ID: 14667276
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-induced renal salt wasting syndrome.
    Hamdi T, Latta S, Jallad B, Kheir F, Alhosaini MN, Patel A.
    South Med J; 2010 Aug; 103(8):793-9. PubMed ID: 20622742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial.
    Ravry MJ, Moore MR, Omura GA, Esseese I, Bartolucci A.
    Cancer Treat Rep; 1985 Dec; 69(12):1457-8. PubMed ID: 4075322
    [No Abstract] [Full Text] [Related]

  • 6. [Early phase II study of FK352 in cisplatin-induced nephropathy. Niigata Prefecture FK352 Study Group].
    Yoshizawa H, Suzuki E, Arakawa M.
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2085-94. PubMed ID: 9838911
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Hyponatremia during treatment with cisplatin].
    Peyrade F, Taillan B, Lebrun C, Bendini JC, Passerron C, Dujardin P.
    Presse Med; 1997 Oct 25; 26(32):1523-5. PubMed ID: 9435831
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Renal-salt wasting syndrome in a patient with CDDP containing chemotherapy for recurrent non-small-cell lung cancer].
    Suzuki H, Ohsugi J, Saito T, Hoshino M, Higuchi M, Kitamura M, Kudoh A, Midorikawa S, Gotoh M.
    Gan To Kagaku Ryoho; 2011 Dec 25; 38(13):2635-8. PubMed ID: 22189232
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.
    Panettiere FJ, Leichman LP, Tilchen EJ, Chen TT.
    Cancer Treat Rep; 1984 Dec 25; 68(7-8):1023-4. PubMed ID: 6540144
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the rates of cisplatin (cDDP)--induced nephrotoxicity associated with sodium loading or sodium loading with forced diuresis as a preventative measure.
    Leu L, Baribeault D.
    J Oncol Pharm Pract; 2010 Sep 25; 16(3):167-71. PubMed ID: 19759050
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyponatremia and renal sodium wasting in patients receiving cisplatinum.
    Vassal G, Rubie H, Kalifa C, Hartmann O, Lemerle J.
    Pediatr Hematol Oncol; 1987 Sep 25; 4(4):337-44. PubMed ID: 3152940
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K, Milner R, Lurie D, Adin C.
    Vet Comp Oncol; 2008 Mar 25; 6(1):1-18. PubMed ID: 19178659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.